Skip to main content
PODD
NASDAQ Industrial Applications And Services

Insulet Initiates Voluntary Recall of Omnipod 5 Pods Due to Manufacturing Defect, Expects Up to $40M in Costs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$222
Mkt Cap
$16.618B
52W Low
$233.29
52W High
$354.88
52W Position info
4.8% below low
Off High info
37% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

PODD is trading near its 52-week low of $233.29 (4.8% below the low).

Summary

Insulet announced a voluntary medical device correction for certain Omnipod 5 Pods due to a manufacturing defect, expecting up to $40 million in costs, but maintains its 2026 guidance.


Key Events · Legal and Risk Events · PODD

  • Voluntary Medical Device Correction Initiated

    Insulet initiated a voluntary medical device correction for specific lots of its Omnipod® 5 Pods due to a manufacturing issue that could cause insulin under-delivery.

  • Serious Adverse Events Reported

    The company has received 18 reports of serious adverse events, including hospitalizations and diabetic ketoacidosis (DKA), associated with the defect.

  • Estimated Financial Impact

    Insulet expects to incur up to $40 million in costs in 2026 related to this correction, which will be excluded from adjusted results.

  • 2026 Guidance Unchanged

    Despite the recall and associated costs, Insulet is not revising its previously issued 2026 financial guidance.


Analysis · PODD · Industrial Applications And Services

This 8-K details Insulet's voluntary medical device correction for specific lots of its Omnipod® 5 Pods, citing a manufacturing issue that could lead to insulin under-delivery and serious adverse events like diabetic ketoacidosis (DKA). While the company expects up to $40 million in costs and has not changed its 2026 guidance, the recall of a critical medical device due to safety concerns, especially with 18 reported serious adverse events, poses a significant reputational risk and could impact patient trust. Investors should monitor the long-term impact on product adoption and regulatory scrutiny.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PODD was trading at $222.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.6B. The 52-week trading range was $233.29 to $354.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PODD - Latest Insights

PODD
Nov 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $165.02
Real-time Price: $142.80 info
Change: -$22.22 (-13%) info
Market Cap: $9.711B info
PODD
Nov 04, 2026, 2:21 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $162.27
Real-time Price: $142.80 info
Change: -$19.46 (-12%) info
Market Cap: $9.711B info
PODD
Nov 04, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.77
Real-time Price: $142.80 info
Change: -$12.97 (-8%) info
Market Cap: $9.711B info
PODD
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $155.77
Real-time Price: $142.80 info
Change: -$12.97 (-8%) info
Market Cap: $9.711B info
PODD
Aug 05, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $144.52
Real-time Price: $142.80 info
Change: -$1.72 (-1%) info
Market Cap: $9.711B info